PETV vs. ICAD, AMIX, XAIR, MODD, GBS, CODX, AKLI, ICU, RVP, and TTOO
Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include iCAD (ICAD), Autonomix Medical (AMIX), Beyond Air (XAIR), Modular Medical (MODD), GBS (GBS), Co-Diagnostics (CODX), Akili (AKLI), SeaStar Medical (ICU), Retractable Technologies (RVP), and T2 Biosystems (TTOO). These companies are all part of the "surgical & medical instruments" industry.
PetVivo (NASDAQ:PETV) and iCAD (NASDAQ:ICAD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.
iCAD has a consensus target price of $5.00, suggesting a potential upside of 244.83%. Given iCAD's higher probable upside, analysts clearly believe iCAD is more favorable than PetVivo.
24.6% of PetVivo shares are owned by institutional investors. Comparatively, 24.6% of iCAD shares are owned by institutional investors. 20.1% of PetVivo shares are owned by insiders. Comparatively, 12.0% of iCAD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
iCAD received 228 more outperform votes than PetVivo when rated by MarketBeat users.
In the previous week, iCAD had 3 more articles in the media than PetVivo. MarketBeat recorded 3 mentions for iCAD and 0 mentions for PetVivo. iCAD's average media sentiment score of 0.79 beat PetVivo's score of 0.00 indicating that iCAD is being referred to more favorably in the news media.
iCAD has a net margin of -15.20% compared to PetVivo's net margin of -1,016.64%. iCAD's return on equity of -14.00% beat PetVivo's return on equity.
iCAD has higher revenue and earnings than PetVivo. iCAD is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.
PetVivo has a beta of 2.15, suggesting that its share price is 115% more volatile than the S&P 500. Comparatively, iCAD has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500.
Summary
iCAD beats PetVivo on 11 of the 15 factors compared between the two stocks.
Get PetVivo News Delivered to You Automatically
Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
